Synthetic control arms in clinical trials: Making it happen
Posted:
Can combining #AI tech & #RWD hold the key to overcoming challenges in #clinicaltrial design?
Join Sensyne Health on 24th February 2:00 p.m. GMT as experts discuss the application of #SyntheticControlArms – a new way of approaching clinical trials.
A new AI framework can detect neurological disorders by analyzing speech with over 90% accuracy. The model, called CTCAIT, captures subtle patterns in voice that may indicate early symptoms of diseases like Parkinson’s, Huntington’s, and Wilson disease.
Read more here.
Attendees
Sponsors and Exhibitors
Contact us